Fexofenadine hydrochloride
Term · Oncology and biomedicine · MLC-T-ONC-013574
The hydrochloride salt form of fexofenadine, a carboxylated metabolic derivative of terfenadine and third generation selective histamine H1-receptor antagonist with antihistaminic and non-sedative effects. Fexofenadine competitively binds peripheral H1-receptors, thereby stabilizing an inactive conformation of the receptor. Consequently histamine binding and activity as a result of mast-cell degranulation followed by the release of multiple inflammatory mediators, such as interleukins, prostaglandin and leukotriene precursors, is blocked, thereby preventing the triggering of pro-inflammatory pathways.
| Identifier | MLC-T-ONC-013574 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | fexofenadine HCl |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013574",
"term": "Fexofenadine hydrochloride",
"field": "Oncology and biomedicine",
"definition": "The hydrochloride salt form of fexofenadine, a carboxylated metabolic derivative of terfenadine and third generation selective histamine H1-receptor antagonist with antihistaminic and non-sedative effects. Fexofenadine competitively binds peripheral H1-receptors, thereby stabilizing an inactive conformation of the receptor. Consequently histamine binding and activity as a result of mast-cell degranulation followed by the release of multiple inflammatory mediators, such as interleukins, prostaglandin and leukotriene precursors, is blocked, thereby preventing the triggering of pro-inflammatory pathways.",
"synonyms": [
"fexofenadine HCl"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/fexofenadine-hydrochloride/"
}
Record 7,243 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.